Skip to main content
. 2024 Dec 5;26(50):10903–10909. doi: 10.1021/acs.orglett.4c04076

Figure 1.

Figure 1

(a) Examples of commercially available drugs containing a 3,3-diarylpropyl amine core. (b) Examples of biologically active compounds with a 4-aryl-substituted THQ core. (c) Previous AH approaches to access 3,3-diarylpropyl amines and strategy envisaged in this study.